MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 535126 | Name: Toquizine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Toquizine is an anticholinergic.

Chemical Structure

Toquizine
CAS#7125-71-5

Theoretical Analysis

MedKoo Cat#: 535126

Name: Toquizine

CAS#: 7125-71-5

Chemical Formula: C23H29N5O

Exact Mass: 391.2372

Molecular Weight: 391.52

Elemental Analysis: C, 70.56; H, 7.47; N, 17.89; O, 4.09

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Toquizine
IUPAC/Chemical Name
1H-Pyrazole-1-carboxamide, N-(4-ethyl-4,6,6a,7,8,9,10,10a-octahydro-7-methylindolo(4,3-fg)quinolin-9-yl)-3,5-dimethyl-
InChi Key
ZSJNNQSQILSGMP-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H29N5O/c1-5-27-12-16-10-21-19(18-7-6-8-20(27)22(16)18)11-17(13-26(21)4)24-23(29)28-15(3)9-14(2)25-28/h6-9,12,17,19,21H,5,10-11,13H2,1-4H3,(H,24,29)
SMILES Code
O=C(N1N=C(C)C=C1C)NC(CC23)CN(C)C3CC4=CN(CC)C5=C4C2=CC=C5
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 391.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: ortho-toluidine. IARC Monogr Eval Carcinog Risks Hum. 2000;77:267-322. PMID: 11100404; PMCID: PMC7197284. 2: 4-Chloro-ortho-toluidine. IARC Monogr Eval Carcinog Risks Hum. 2000;77:323-39. PMID: 11100405; PMCID: PMC7197272. 3: 5-Nitro-ortho-toluidine. IARC Monogr Eval Carcinog Risks Hum. 1990;48:169-77. PMID: 2197459. 4: Scott LJ. Teriflunomide: A Review in Relapsing-Remitting Multiple Sclerosis. Drugs. 2019 Jun;79(8):875-886. doi: 10.1007/s40265-019-01135-8. PMID: 31098896. 5: Dunnick JK, Shockley KR, Morgan DL, Brix A, Travlos GS, Gerrish K, Michael Sanders J, Ton TV, Pandiri AR. Hepatic transcriptomic alterations for N,N-dimethyl-p-toluidine (DMPT) and p-toluidine after 5-day exposure in rats. Arch Toxicol. 2017 Apr;91(4):1685-1696. doi: 10.1007/s00204-016-1831-7. Epub 2016 Sep 16. PMID: 27638505; PMCID: PMC5364093. 6: Toyoda T, Matsushita K, Morikawa T, Yamada T, Miyoshi N, Ogawa K. Distinct differences in the mechanisms of mucosal damage and γ-H2AX formation in the rat urinary bladder treated with o-toluidine and o-anisidine. Arch Toxicol. 2019 Mar;93(3):753-762. doi: 10.1007/s00204-019-02396-8. Epub 2019 Jan 17. PMID: 30656379. 7: Stasik MJ. Harnblasenkrebs durch 4-Chlor-o-toluidin [4-Chloro-o-toluidine- induced bladder cancer]. Dtsch Med Wochenschr. 1991 Sep 20;116(38):1444-7. German. doi: 10.1055/s-2008-1063771. PMID: 1893857. 8: Zhao J, Xia H, Yu T, Jin L, Li X, Zhang Y, Shu L, Zeng L, He Z. A colorimetric assay for vanillin detection by determination of the luminescence of o-toluidine condensates. PLoS One. 2018 Apr 20;13(4):e0194010. doi: 10.1371/journal.pone.0194010. PMID: 29677193; PMCID: PMC5909897. 9: Eitaki Y, Nakano M, Kawai T, Omae K, Takebayashi T. Biological monitoring of o-toluidine in urine pretreated by an enzymatic deconjugation method. J Occup Health. 2019 Sep;61(5):349-357. doi: 10.1002/1348-9585.12058. Epub 2019 Apr 19. PMID: 31002462; PMCID: PMC6718832. 10: National Toxicology Program. p-Chloro-o-toluidine and its hydrochloride. Rep Carcinog. 2011;12:104-6. PMID: 21850149. 11: Totsuka Y, Wakabayashi K. Biological significance of aminophenyl-β-carboline derivatives formed from co-mutagenic action of β-carbolines and aniline and o-toluidine and its effect on tumorigenesis in humans: A review. Mutat Res. 2020 Feb-Mar;850-851:503148. doi: 10.1016/j.mrgentox.2020.503148. Epub 2020 Jan 28. PMID: 32247557. 12: Sellers C, Markowitz S. Reevaluating the carcinogenicity of ortho-toluidine: a new conclusion and its implications. Regul Toxicol Pharmacol. 1992 Dec;16(3):301-17. doi: 10.1016/0273-2300(92)90010-7. PMID: 1293647. 13: Danford N. The genetic toxicology of ortho-toluidine. Mutat Res. 1991 Nov;258(3):207-36. doi: 10.1016/0165-1110(91)90010-s. PMID: 1719402. 14: Cappelletti G, Pifferi V, Mostoni S, Falciola L, Di Bari C, Spadavecchia F, Meroni D, Davoli E, Ardizzone S. Hazardous o-toluidine mineralization by photocatalytic bismuth doped ZnO slurries. Chem Commun (Camb). 2015 Jul 4;51(52):10459-62. doi: 10.1039/c5cc02620b. PMID: 26028215. 15: Johansson GM, Jönsson BA, Axmon A, Lindh CH, Lind ML, Gustavsson M, Broberg K, Boman A, Meding B, Lidén C, Albin M. Exposure of hairdressers to ortho- and meta-toluidine in hair dyes. Occup Environ Med. 2015 Jan;72(1):57-63. doi: 10.1136/oemed-2013-101960. Epub 2014 Jun 9. PMID: 24912758; PMCID: PMC4283615. 16: TOLUIDINE blue. Whats New. 1950 Oct;150:9-10. PMID: 24540246. 17: Dunnick JK, Merrick BA, Brix A, Morgan DL, Gerrish K, Wang Y, Flake G, Foley J, Shockley KR. Molecular Changes in the Nasal Cavity after N, N-dimethyl-p- toluidine Exposure. Toxicol Pathol. 2016 Aug;44(6):835-47. doi: 10.1177/0192623316637708. Epub 2016 Apr 20. PMID: 27099258; PMCID: PMC5804348. 18: Pargoletti E, Mostoni S, Rassu G, Pifferi V, Meroni D, Falciola L, Davoli E, Marelli M, Cappelletti G. Zn- vs Bi-based oxides for o-toluidine photocatalytic treatment under solar light. Environ Sci Pollut Res Int. 2017 Mar;24(9):8287-8296. doi: 10.1007/s11356-017-8430-x. Epub 2017 Feb 3. PMID: 28160178. 19: Borges LV, Mattar R, Silva JMKD, Silva ALWD, Carrilho FJ, Hashimoto CL. FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS. Arq Gastroenterol. 2018 Apr-Jun;55(2):128-132. doi: 10.1590/S0004-2803.201800000-22. PMID: 30043860. 20: Su CC, Fan CC, Anotai J, Lu MC. Effect of the iron oxide catalyst on o-toluidine oxidation by the fluidized-bed fenton process. Environ Technol. 2014 Jan-Feb;35(1-4):89-94. doi: 10.1080/09593330.2013.811543. PMID: 24600845.

View History

Torbafylline

Torbafylline